Trial Details

Authorised
Basic Information
Clinical ID c2586
Identifier EUCTR2018-002982-20-GB
Trial Title A Pilot Study to assess the efficacy and safety of reduced dose oral iron in the treatment of iron deficiency anaemia in inflammatory bowel disease patients - Efficacy and safety of low dose oral iron for anaemia in IBD (CAESAR)
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions Iron deficiency anaemia in inflammatory bowel disease MedDRA version: 20.0_Level: LLT_Classification code 10002062_Term: Anaemia iron deficiency_System Organ Class: 100000004851_ MedDRA version: 20.1_Level: PT_Classification code 10021972_Term: Inflammatory bowel disease_System Organ Class: 10017947 - Gastrointestinal disorders_;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Interventions Trade Name: Ferrous Fumarate Syrup Product Name: Ferrous Fumarate Syrup Product Code: Ferrous fumarate syrup Pharmaceutical Form: Syrup INN or Proposed INN: Ferrous fumarate CAS Number: 141-01-5 Current Sponsor code: NA Other descriptive name: NA Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 140mg-5ml
Participant Information
Sponsor Royal Liverpool University Hospital
City -
Country/Region United Kingdom
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement -
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE4
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -